HCPCS Level II drug code
J0695 — Injection, ceftolozane 50 mg and tazobactam 25 mg
In short
J0695 is the HCPCS Level II code for injection, ceftolozane 50 mg and tazobactam 25 mg. CMS assigns NDCs for Zerbaxa to it. The Medicare Part B payment limit is $10.015 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, ceftolozane 50 mg and tazobactam 25 mg
- Short descriptor
- Inj ceftolozane tazobactam
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2016
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. CMS note: Inflation-adjusted coinsurance. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J0695
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 1 NDC to J0695 for Zerbaxa. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Zerbaxa | 67919-0030-01 | Merck Sharp & Dohme LLC | 10 × 1 | 200 |
J0695: common questions
- Is J0695 a CPT code?
- No. J0695 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J0695?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 1 NDC under J0695, for Zerbaxa. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J0695?
- $10.015 per 75mg (50mg cft/25mg taz), effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.